Similar Diseases
- ADSD
- Autosomal recessive dopa-responsive dystonia
- SCA41
- Autosomal dominant Huntington-like neurodegenerative disorder
- Dementia, Familial Nonspecific
- Cerebellar ataxia with azoospermia and intellectual disability
- Olivopontocerebellar Atrophy, X-Linked
- Autosomal recessive early-onset Parkinson disease 7
- Brain Iron Accumulation type I syndrome
- NADGP
Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin
Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)
Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies
Results for Query ‹ ADSD medication ›
Spasmodic dysphonia – Treatment | Botulinum toxin
Botulinum toxin (Botox) is often used to improve some symptoms of spasmodic dysphonia. Whilst the level of evidence for its use is limited, it remains a popular choice for many patients due to the predictability and low chance of long term side effects. It results in periods of some improvement. The duration of benefit averages 10–12 weeks before the patient returns to baseline. Repeat injection is required to sustain good vocal production.
Spasmodic dysphonia – Treatment
There are a number of potential treatments for spasmodic dysphonia, including botox, surgery and voice therapy. A number of medications have also been tried including anticholinergics (such as benztropine) which have been found to be effective in 40-50% of people, but which are associated with a number of side effects.